Last updated 2026-07-20
- Raised Pre-Seed round led by NGT HealthCare II, Dec 2021
Total raised
—
Last: Undisclosed Round 2022-01
Stage
Pre-Seed
Founded
2022
Headcount
5
HQ
Nazareth, Israel
Sector
Health Tech & Life Sciences
About
I-Derm Pharma is a biotechnology company focused on developing a first-in-class oral therapy for treating autoimmune inflammatory skin diseases such as Psoriasis. Their proprietary small molecule therapy introduces a novel mechanism of action that targets a pathway within the local skin's inflammatory pathway, modulating inflammation without compromising the immune system. The oral solution aims to offer enhanced safety, low toxicity, and high efficacy, providing a convenient alternative to biologic injections.
Funding history · 1 round · — total
2021-12
Pre-Seed
Undisclosed
★ NGT HealthCare II
Headcount over time
From 6 (2023-03) to 5 (2025-05) · -1 (-17%) · 2 points · source: Finder history + radar grounding
Q&A
- What is I-Derm Pharma's primary focus?
- I-Derm Pharma is developing a first-in-class oral therapy for moderate-to-severe psoriasis, targeting inflammatory autoimmune skin diseases.
- When was I-Derm Pharma founded?
- I-Derm Pharma was founded in January 2022.
- How many employees does I-Derm Pharma currently have?
- I-Derm Pharma has 1-10 employees.
- What is the current stage of I-Derm Pharma's product development?
- I-Derm Pharma's product is in the R&D stage, with the company advancing its lead candidate toward IND.
- Which investor participated in I-Derm Pharma's funding round in January 2022?
- NGT HealthCare II participated in I-Derm Pharma's funding round in January 2022.
- What is I-Derm Pharma's current funding stage?
- I-Derm Pharma is currently in the Pre-Seed funding stage.
- What type of therapy is I-Derm Pharma developing?
- I-Derm Pharma is developing a proprietary small-molecule oral therapy.
- Does I-Derm Pharma hold any patents?
- Yes, I-Derm Pharma holds one patent.
Team · 3
Dr. Sharon Navon
Founder · Co-founder & CEO
Prof. Eli Sprecher
Founder · Co-founder
Dr. Ofer Sarig
Founder · Co-founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife Sciences
Business model
B2B2C
Highlights
1 PatentsVerified
Tags
dermatologypharmaceuticalsautoimmune-diseasesoral-drugs
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | idermpharma.com/ |
|---|
Identifiers & details
| Founded | 2022-1 |
|---|---|
| Employees (exact) | 5 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | idermpharma.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516549672 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2022-01-30 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | ואדי אל-חאג' 13 נצרת |